Correlation Between Sonnet Biotherapeutics and Neurobo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Neurobo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Neurobo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Neurobo Pharmaceuticals, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Neurobo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Neurobo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Neurobo Pharmaceuticals.
Diversification Opportunities for Sonnet Biotherapeutics and Neurobo Pharmaceuticals
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Sonnet and Neurobo is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Neurobo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobo Pharmaceuticals and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Neurobo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobo Pharmaceuticals has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Neurobo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Sonnet Biotherapeutics and Neurobo Pharmaceuticals
Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to under-perform the Neurobo Pharmaceuticals. In addition to that, Sonnet Biotherapeutics is 1.11 times more volatile than Neurobo Pharmaceuticals. It trades about -0.08 of its total potential returns per unit of risk. Neurobo Pharmaceuticals is currently generating about -0.02 per unit of volatility. If you would invest 1,136 in Neurobo Pharmaceuticals on August 27, 2024 and sell it today you would lose (899.00) from holding Neurobo Pharmaceuticals or give up 79.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sonnet Biotherapeutics Holding vs. Neurobo Pharmaceuticals
Performance |
| Timeline |
| Sonnet Biotherapeutics |
| Neurobo Pharmaceuticals |
Sonnet Biotherapeutics and Neurobo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sonnet Biotherapeutics and Neurobo Pharmaceuticals
The main advantage of trading using opposite Sonnet Biotherapeutics and Neurobo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Neurobo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will offset losses from the drop in Neurobo Pharmaceuticals' long position.| Sonnet Biotherapeutics vs. ZyVersa Therapeutics | Sonnet Biotherapeutics vs. Allarity Therapeutics | Sonnet Biotherapeutics vs. Immix Biopharma | Sonnet Biotherapeutics vs. Cns Pharmaceuticals |
| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets |